Colgate-Palmolive Company Congressional Trading
According to U.S. congressional financial disclosures filed under the STOCK Act, members of Congress have reported 159 trades in Colgate-Palmolive Company (NYSE: CL) since 2013, across 31 members, worth an estimated $2.2M in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts). 82 buys against 77 sells, a modestly buy-led skew, with Democratic members responsible for 60% of the trades and Republican members 40%. The most recent disclosure shown was filed February 2026, and Ro Khanna has filed the most CL transactions among those shown, with 12. Other recent filers include Rick Larsen, Julie Johnson, and Lisa Mcclain. These figures are drawn from public House and Senate periodic transaction reports and reflect what members were required to disclose, not the current market value of any position. For the full record, including the month-by-month buy and sell timeline, the party breakdown, top buyers and sellers, and every individual filing, see the Colgate-Palmolive Company (CL) stock overview and the complete trade table below.
Data updated
Price & congressional trade timeline
Party breakdown
Colgate-Palmolive congressional trading activity
| Politician | Published | Traded | Filed After | Type | Size | Return | |
|---|---|---|---|---|---|---|---|
 Ro Khanna House | Feb 6, 2026 | Jan 13, 2026 | 24 days | BUY |  $1,001 - $15,000 | N/A | |
Ro Khanna House | Dec 8, 2025 | Nov 10, 2025 | 28 days | BUY | $15,001 - $50,000 | N/A | |
Ro Khanna House | Dec 8, 2025 | Nov 3, 2025 | 35 days | BUY | $1,001 - $15,000 | N/A | |
Ro Khanna House | Nov 6, 2025 | Oct 7, 2025 | 30 days | SELL | $1,001 - $15,000 | N/A | |
 Rick Larsen House | Oct 16, 2025 | Oct 6, 2025 | 10 days | SELL | $1,001 - $15,000 | N/A | |
Ro Khanna House | Oct 3, 2025 | Sep 29, 2025 | 4 days | SELL | $1,001 - $15,000 | N/A | |
 Julie Johnson House | Oct 7, 2025 | Sep 25, 2025 | 12 days | SELL | $1,001 - $15,000 | N/A | |
 Lisa Mcclain House | Oct 22, 2025 | Sep 11, 2025 | 41 days | SELL | $1,001 - $15,000 | N/A | |
 Tim Moore House | Oct 10, 2025 | Sep 10, 2025 | 30 days | SELL | $1,001 - $15,000 | N/A | |
Ro Khanna House | Oct 3, 2025 | Sep 9, 2025 | 24 days | BUY | $1,001 - $15,000 | N/A |
Colgate-Palmolive (CL) congressional trading FAQ
Can members of Congress legally trade Colgate-Palmolive (CL) stock?
Yes. Members of Congress are permitted to trade individual stocks, including Colgate-Palmolive (CL), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. BullishWhales tracks those disclosures; it does not imply any trade was improper.
Are congressional Colgate-Palmolive (CL) trades public?
Yes. Every congressional trade in Colgate-Palmolive (CL) on this page comes from mandatory public STOCK Act disclosure filings, which are filed with a delay and may be revised.
How many times has Congress traded Colgate-Palmolive (CL)?
Members of Congress have disclosed 159 trades in Colgate-Palmolive (CL) worth $2.2M across 31 members, according to public STOCK Act filings.
Which members of Congress have traded Colgate-Palmolive (CL)?
Recent and active filers of Colgate-Palmolive (CL) disclosures include Ro Khanna, Lisa Mcclain, Rick Larsen. The full member-by-member trade list is on this page.
Do Democrats or Republicans trade Colgate-Palmolive (CL) more?
Across disclosed Colgate-Palmolive (CL) trades, 60% were by Democrats and 40% by Republicans, led by Democrats (60%).
What is the most recent congressional Colgate-Palmolive (CL) trade?
The most recent disclosed Colgate-Palmolive (CL) trade was a purchase by Ro Khanna, filed Feb 5, 2026.
Browse all stocks Congress tradesCongressional trading overviewColgate-Palmolive (CL) stock overview
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. The Tide Score and other figures are generated algorithmically from public filings and market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.